Tomography and Prognostic Indices in the State of the Art of Evaluation in Hospitalized Patients with COVID-19 Pneumonia
Sergio Críales-Vera,
Huitzilihuitl Saucedo-Orozco,
Pedro Iturralde-Torres,
Gustavo Martínez-Mota,
Estefanía Dávila-Medina,
Verónica Guarner-Lans,
Linaloe Manzano-Pech,
Israel Pérez-Torres,
María Elena Soto
Affiliations
Sergio Críales-Vera
Department of Computed Tomography, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Col. Sección XVI, Del. Tlalpan, Mexico City 14080, Mexico
Huitzilihuitl Saucedo-Orozco
Cardioneumology Department, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Col. Sección XVI, Del. Tlalpan, Mexico City 14080, Mexico
Pedro Iturralde-Torres
Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Col. Sección XVI, Del. Tlalpan, Mexico City 14080, Mexico
Gustavo Martínez-Mota
Department of Computed Tomography, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Col. Sección XVI, Del. Tlalpan, Mexico City 14080, Mexico
Estefanía Dávila-Medina
Department of Computed Tomography, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Col. Sección XVI, Del. Tlalpan, Mexico City 14080, Mexico
Verónica Guarner-Lans
Department of Physiology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Col. Sección XVI, Del. Tlalpan, Mexico City 14080, Mexico
Linaloe Manzano-Pech
Department of Cardiovascular Biomedicine, Instituto Nacional de Cardiologíaa Ignacio Chávez, Juan Badiano 1, Col. Sección XVI, Del. Tlalpan, Mexico City 14080, Mexico
Israel Pérez-Torres
Department of Cardiovascular Biomedicine, Instituto Nacional de Cardiologíaa Ignacio Chávez, Juan Badiano 1, Col. Sección XVI, Del. Tlalpan, Mexico City 14080, Mexico
María Elena Soto
Department of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Col. Sección XVI, Del. Tlalpan, Mexico City 14080, Mexico
Evaluation in medical emergencies of COVID-19 patients represents a challenge to regulate preventive and timely management. There are key imaging and laboratory tools to classify the severity. The aim of the study was to evaluate the chest CT score performance and prognostic indices in COVID-19 patients to predict the progression to critical illness. This was a retrospective study between run between April and December 2020, in which 109 patients were included. Patients of any age and gender and who required hospitalization due to a confirmed COVID-19 diagnosis by RT-PCR and chest CT and laboratory were analyzed. In 75% of them, there was at least one comorbidity, and 30% developed critical illness, and the average mortality was 10%. In 49.5%, there was a CORADS-5 on admission, and in 50%, there was a peripheral distribution of the interstitial infiltrate in the left lower lobe. The risk factors were FiO2, CT score > 18, and the NRL index. The combination of the high-risk Quick COVID-19 Severity Index (qCSI) plus CT score > 18 indices was the best prediction index for the development of a critical condition. The combined use of indices in infected COVID-19 patients showed diagnostic accuracy and predicted severity. Imaging and the laboratory tests are key tools independent of the wave of recurrence.